KATHLEEN CASTANO: Open Payments
NPI 1588429773 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 30 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 8 | $188 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| ANI Pharmaceuticals, Inc. | 3 | $72 |
| Grifols USA, LLC | 2 | $61 |
| Astellas Pharma US Inc | 2 | $59 |
| United Therapeutics Corporation | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
| Baxter Healthcare | 2 | $40 |
| ABBVIE INC. | 2 | $32 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: OPSUMIT, NUCALA, PURIFIED CORTROPHIN GEL, Prolastin-C Liquid, Cresemba, UPTRAVI, DUPIXENT, Hillrom - Vest System Model 105 Home Care.
Industry payments across TX — which companies pay providers there.
